Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy (Q43294366)
Jump to navigation
Jump to search
scientific article published on 11 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy |
scientific article published on 11 August 2009 |
Statements
1 reference
Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy (English)
1 reference
Alfred Maelicke
1 reference
Anja Hoeffle-Maas
1 reference
Juergen Ludwig
1 reference
Arno Maus
1 reference
Marek Samochocki
1 reference
Ulrich Jordis
1 reference
Andreas K E Koepke
1 reference
11 August 2009
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference